Koers Changjiang Pharmaceutical Group Co., Ltd.
Aandelen
300391
CNE100001XN8
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,05 CNY | -5,15% | +10,66% | -47,67% |
Omzet 2021 | 2,36 mld. 326 mln. 304 mln. | Omzet 2022 | 1,62 mld. 223 mln. 208 mln. | Marktkapitalisatie | 3,42 mld. 472 mln. 440 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 49 mln. 6,77 mln. 6,31 mln. | Nettowinst (verlies) 2022 | -23 mln. -3,18 mln. -2,96 mln. | EV/omzet 2021 | 2,61 x |
Nettoschuld 2021 | 843 mln. 117 mln. 109 mln. | Nettoschuld 2022 | 1 mld. 138 mln. 129 mln. | EV/omzet 2022 | 2,73 x |
K/w-verhouding 2021 |
108
x | K/w-verhouding 2022 |
-147
x | Werknemers | 613 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 66,46% |
1 dag | +7,56% | ||
1 week | +16,67% | ||
Lopende maand | -15,78% | ||
1 maand | -15,78% | ||
3 maanden | -33,59% | ||
6 maanden | -34,41% | ||
Lopend jaar | -44,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lu Hong Ning
BRD | Director/Board Member | 53 | 11-07-22 |
Yue Xiao Yang
PRN | Corporate Officer/Principal | 44 | 01-05-15 |
Jin Hui Sun
PRN | Corporate Officer/Principal | 61 | 29-10-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lu Hong Ning
BRD | Director/Board Member | 53 | 11-07-22 |
Jin Hui Sun
PRN | Corporate Officer/Principal | 61 | 29-10-15 |
Yong Xu
BRD | Director/Board Member | 45 | 29-03-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 4,05 | -5,15% | 14 470 500 |
29-04-24 | 4,27 | +7,56% | 12 234 930 |
26-04-24 | 3,97 | -4,57% | 12 931 300 |
25-04-24 | 4,16 | +2,97% | 6 447 250 |
24-04-24 | 4,04 | +4,94% | 6 906 346 |
slotkoers Shenzhen S.E., 29 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-44,83% | 207 mln. | |
+26,47% | 664 mld. | |
+25,10% | 567 mld. | |
-6,33% | 354 mld. | |
+19,35% | 330 mld. | |
+4,23% | 286 mld. | |
+14,36% | 234 mld. | |
+4,62% | 199 mld. | |
-9,82% | 196 mld. | |
-4,04% | 148 mld. |